George Kemble serves as Executive at Sagimet Biosciences Inc., where they oversee executive responsibilities. Since joining the company, George Kemble has executed 5 insider transactions totaling $408.3K, demonstrating a bearish approach to their equity position. Their most recent transaction on Nov 20, 2025 involved selling 37,688 shares valued at $289.8K.
George Kemble currently holds 81,005 shares of Sagimet Biosciences Inc. (SGMT), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, George Kemble has been a net seller of SGMT stock. They have purchased $0 and sold $408.3K worth of shares.
George Kemble's most recent insider trade was on Nov 20, 2025, when they sold 37,688 shares at $7.69 per share.
Get notified when new Form 4 filings are submitted
| $3.17 |
| Planned |
| Jul 19, 2024 | SGMT | $43.6K | Sale | 14,062 | $3.10 | Discretionary |
| Nov 17, 2023 | SGMT | $0 | Award | 150,750 | $N/A | Discretionary |
| Sep 7, 2023 | SGMT | $4.4K | Option Exercise | 5,630 | $0.79 | Discretionary |